YEAST TRAFFIC LIGHT PNA FISH

K080719 · Advandx, Inc. · JXB · Sep 12, 2008 · Microbiology

Device Facts

Record IDK080719
Device NameYEAST TRAFFIC LIGHT PNA FISH
ApplicantAdvandx, Inc.
Product CodeJXB · Microbiology
Decision DateSep 12, 2008
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 866.2660
Device ClassClass 1

Intended Use

Yeast Traffic Light PNA FISH is a multicolor, qualitative nucleic acid hybridization assay intended for the identification of Candida albicans and/or Candida parapsilosis, identification of Candida tropicalis and identification of Candida glabrata and/or Candida krusei from positive blood cultures. The test does not distinguish between C. glabrata and C. krusei. The test does not distinguish between C. albicans and C. parapsilosis.

Device Story

Yeast Traffic Light PNA FISH is a qualitative nucleic acid hybridization assay; utilizes Peptide Nucleic Acid (PNA) probes for identification of specific Candida species from positive blood cultures. Input: positive blood culture samples. Process: hybridization of fluorescently labeled PNA probes to target ribosomal RNA sequences within yeast cells. Output: visual identification of Candida species via fluorescence microscopy. Used in clinical microbiology laboratories by trained laboratory personnel. Provides rapid identification of yeast pathogens to assist clinicians in selecting appropriate antifungal therapy, potentially improving patient outcomes by enabling targeted treatment.

Technological Characteristics

Multicolor nucleic acid hybridization assay using Peptide Nucleic Acid (PNA) probes. Fluorescence-based detection. Manual procedure requiring fluorescence microscopy.

Indications for Use

Indicated for the qualitative identification of Candida species (C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, C. krusei) from positive blood cultures. Does not distinguish between C. glabrata/C. krusei or C. albicans/C. parapsilosis.

Regulatory Classification

Identification

A microorganism differentiation and identification device is a device intended for medical purposes that consists of one or more components, such as differential culture media, biochemical reagents, and paper discs or paper strips impregnated with test reagents, that are usually contained in individual compartments and used to differentiate and identify selected microorganisms. The device aids in the diagnosis of disease.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with its wings spread, surrounded by a circular border. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is written around the border of the circle. ## Public Health Service Food and Drug Administration 2098 Gaither Road Rockville MD 20850 Ms. Paula E. Bulger Director of Regulatory Affairs AdvanDx Inc. 10A Roessler Road Woburn, MA 01801, USA SEP 1 2 2008 Re: K080719 > Trade/Device Name: AdvanDx Ycast Traffic Light PNA FISH Regulation Number: 21 CFR 866.2660 Regulation Name: Microorganisms differentiation and identification device Regulatory Class: Class I Product Code: JXB Dated: August 13, 2008 Reccived: August 15, 2008 Dear Ms. Bulger: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). {1}------------------------------------------------ ## Page 2 - This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at 240-276-0450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or ' (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely vours. Sally attaym Sally A. Hojvat, M.Sc., Ph.D. Director Division of Microbiology Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## INDICATIONS FOR USE STATEMENT 510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________ Device Name: Yeast Traffic Light PNA FISH Indications for Use: Yeast Traffic Light PNA FISH is a multicolor, qualitative nucleic acid hybridization assay intended for the identification of Candida albicans and/or Candida parapsilosis, identification of Candida tropicalis and identification of Candida glabrata and/or Candida krusei from positive blood cultures. The test does not distinguish between C. glabrata and C. krusei. The test does not distinguish between C. albicans and C. parapsilosis. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Freddie F. Poole Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety 510(k) K086719
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%